Transcept Pharmaceuticals

Retrophin to acquire Transcept Pharmaceuticals

Retrophin announced today that it had made another proposal to acquire all Transcept Pharmaceuticals Inc. shares of common stock valued USD4 per share in cash.

Read Full Article

Subscribe to VCpost newsletter

Sign up for our Deals of the Day newsletter.
We will not spam you!

Real Time Analytics